Multimodal home-based rehabilitation intervention after discharge from inpatient geriatric rehabilitation (GeRas): study protocol for a multicenter randomized controlled trial.

"Declarations Ethics approval and consent to participateThe study protocol has been approved by two different ethics committees, as different ethics committees have been responsible for each of the study sites. The Ethics Committee of the Medical Faculty of Heidelberg University approved the study protocol for the consortium-leading study site AGAPLESION BETHANIEN HOSPITAL HEIDELBERG (approval # S-395/2022), whereas the Ethics Committee of the State Medical Association Baden-Württemberg has approved the study protocol for the study sites Robert-Bosch-Hospital Stuttgart and ViDia Christian Clinics Karlsruhe (approval # B-F-2022–057). All procedures in this study involving human participants are in accordance with the recent version of the Declaration of Helsinki. All participants are covered by an insurance while participating in the study. Substantial amendments to the protocol are submitted for approval to the ethical committees and communicated to the trial registry. Written informed consent for study participation is obtained from all of the participants during inpatient rehabilitation prior to study inclusion and baseline assessment. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding Open Access funding enabled and organized by Projekt DEAL. The project is funded by the German Innovation Fund (‘New Forms of Care’) coordinated by the Innovation Committee of the Federal Joint Committee (in German: “Innovationsausschuss beim Gemeinsamen Bundesausschuss”, G-BA, Postfach 120606, 10596 Berlin, Germany; grant # 01NVF20017). The funder had no role in the study design and the decision to submit this manuscript for publication, and will have no role in the collection, management, analysis and interpretation of data, writing the report and the decision to submit the report for publication. For the publication fee we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme “Open Access Publikationskosten” as well as by Heidelberg University."

"Trial registration German Clinical Trials Register (DRKS00029559). Registered on October 05, 2022."